跳至主要内容
临床试验/NCT01542229
NCT01542229已完成不适用

Improving PTSD Service Delivery for Veterans With Severe Mental Illness

VA Office of Research and Development2 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2012年5月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
134
试验地点
2
主要终点
Posttraumatic Stress Disorder (PTSD) Checklist (PCL)

研究概览

简要总结

As in the general population, there is no clear standard of care within Veterans Affairs Medical Centers for treating posttraumatic stress disorder (PTSD) among individuals with severe mental illness (SMI). This is a considerable issue because trauma, posttraumatic stress disorder (PTSD), and severe psychiatric comorbidity are particularly common among Veterans and this symptom presentation clearly exacerbates the overall course and severity of mental illness. This study is significant in that it proposes to establish the efficacy of a frontline exposure based intervention for posttraumatic stress disorder (PTSD), Prolonged Exposure, for improving critical clinical, quality of life, and cost outcomes among Veterans with severe mental illness (SMI) enrolled in VA healthcare. Collectively, it is anticipated that these data will establish a much needed clinical course of action for what is considered a vulnerable yet highly underserved patient population.

详细描述

The overarching aim of this proposal is to compare the efficacy of Prolonged Exposure for posttraumatic stress disorder (PTSD) plus treatment as usual (PE+TAU) relative to treatment as usual (TAU) alone using a randomized, between groups, repeated measures design. One hundred fifty six (156) ethnically/racially diverse male and female Veterans with posttraumatic stress disorder (PTSD) and severe mental illness (SMI) will be recruited from the Charleston VA and affiliated Community Based Outpatient Clinics (CBOCs) during the study time frame. For the investigators' study purposes, severe mental illness (SMI) is defined as (1) the presence of a past year Diagnostic Statistical Manual (DSM-IV) Axis I diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or severe depression (2) resulting in persistent impairment in self-care, work, or social functioning. Veterans will be randomized 1:1 to one of two conditions: PE+TAU or TAU. The active intervention phase is 12 weeks. Veterans randomized to treatment as usual (TAU) will receive support services through the VA potentially inclusive of case management, psychotropic medication management, and/or supportive counseling and Veterans randomized to prolonged exposure (PE) plus treatment as usual (TAU) will receive 12 weekly sessions of prolonged exposure (PE) in addition to treatment as usual (TAU). All participants will be assessed at baseline, 6 weeks, post-treatment, and at 3 and 6 months. Additionally, they will complete two self report forms during sessions 3, 6, and 9.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Posttraumatic Stress Disorder (PTSD) on the Clinician Administered PTSD Scale (CAPS; Blake et al., 1990);
  • A confirmed diagnosis of a psychotic disorder, bipolar disorder, or severe unipolar depression on the Mini Neuropsychiatric Interview (MINI; Sheehan et al., 1998).

排除标准

  • Having a household member who is already enrolled in the study;
  • Active psychosis, mania, or dementia at screening;
  • Suicidal ideation with clear intent;
  • Current substance dependence; and
  • Concurrent enrollment in another clinical trial for PTSD or depression.

研究组 & 干预措施

Arm 1: PE + TAU

Experimental

Prolonged Exposure Therapy +Treatment As Usual

干预措施: Prolonged Exposure for PTSD (PE) + Treatment as Usual (TAU) (Behavioral)

Arm 2: Usual Treatment

Active Comparator

Treatment As Usual

干预措施: Treatment As Usual (TAU) (Behavioral)

结局指标

主要结局

Posttraumatic Stress Disorder (PTSD) Checklist (PCL)

时间窗: pre to post treatment (12 weeks)

The PTSD Checklist (PCL) is a 17-item self-report measure of PTSD symptoms based on DSM-IV criteria. Total scores on the PCL were used, and total scores range from 17 to 85 with higher scores indicative of greater PTSD severity.

Clinician Administered Posttraumatic Stress Disorder Scale (CAPS)

时间窗: pre to post treatment (12 weeks)

The Clinician Administered PTSD (Posttraumatic Stress Disorder; PTSD) Scale (CAPS) is a 30-item structured interview that corresponds to DSM-IV criteria for PTSD. The CAPS can be used to make a current (past month) or lifetime diagnosis of PTSD or to assess symptoms over the past week/month. The CAPS was used to measure current PTSD (yes/no diagnosis) as well as total PTSD severity (scores range 0-136, with higher scores indicative of more severe PTSD).

次要结局

  • Beck Depression Inventory-II (BDI-II)(pre to post treatment (12 weeks))
  • Brief Psychiatric Rating Scale-Extended (BPRS-E)(pre to post treatment (12 weeks))
  • Veterans SF 12 Health Survey (SF-12)(pre to post treatment (12 weeks))
  • Pittsburgh Seep Quality Index(pre to post treatment (12 weeks))

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

PTSD (PostTraumatic Stress Disorder) Services for... | 临床试验